Wyche Fowler, Director at KERYX BIOPHARMACEUTICALS INC (KERX), sold 3,000 shares at $0.21 ($630) on 2008-12-19, disclosed to the SEC on 2008-12-22.
Open-market sale of $630 KERX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KERX | BUY | 2011-08-11 | $15K | — | Filing → |
| ZIOP | BUY | 2011-08-11 | $26K | — | Filing → |
| BDN | SELL | 2010-11-26 | $33K | — | Filing → |